|
Serious adverse events
|
Placebo |
Ticagrelor 90mg bd |
Ticagrelor 60mg bd |
|
Total subjects affected by serious adverse events
|
|
|
|
|
subjects affected / exposed
|
1757 / 6996 (25.11%) |
1918 / 6988 (27.45%) |
1853 / 6958 (26.63%) |
|
number of deaths (all causes)
|
329 |
333 |
290 |
|
number of deaths resulting from adverse events
|
11 |
5 |
14 |
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
|
Acinic cell carcinoma of salivary gland
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acute myeloid leukaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Adenocarcinoma gastric
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Adenocarcinoma of colon
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Adenolymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Adrenal adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ameloblastoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Anaplastic large cell lymphoma T- and null-cell types
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Anogenital warts
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Astrocytoma malignant
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atypical fibroxanthoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
B-cell lymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Basal cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
9 / 6988 (0.13%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 12 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign neoplasm of bladder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign neoplasm of thyroid gland
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign neoplasm of ureter
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign ovarian tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign pancreatic neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign renal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign salivary gland neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign soft tissue neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bile duct adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Bile duct cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biliary neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
5 / 6988 (0.07%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder cancer recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder papilloma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder transitional cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder transitional cell carcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder transitional cell carcinoma recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bone cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Bone cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Bone sarcoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bowen's disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Brain cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Brain neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Brain neoplasm malignant
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Breast cancer female
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Breast cancer male
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Breast cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Breast cancer recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Brenner tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchial carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchioloalveolar carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervix cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervix carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervix carcinoma stage 0
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholangiocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Cholesteatoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Choroid melanoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chronic lymphocytic leukaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chronic myeloid leukaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clear cell renal cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colon adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
7 / 6988 (0.10%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colon cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
14 / 6988 (0.20%) |
14 / 6958 (0.20%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 14 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Colon cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
7 / 6988 (0.10%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 9 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 5 |
|
Colon neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colorectal adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colorectal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diffuse large B-cell lymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Endometrial adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endometrial cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endometrial cancer stage I
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epithelioid mesothelioma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Essential thrombocythaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fallopian tube cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fibroma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Follicle centre lymphoma, follicular grade I, II, III stage IV
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gallbladder adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gallbladder cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Gallbladder cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Gastric adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
8 / 6988 (0.11%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 10 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
Gastrointestinal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal stromal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal stromal tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal tract adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrooesophageal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Glioblastoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
Glioblastoma multiforme
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
Haemangioma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatic cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
Hepatic cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Hepatic neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatocellular carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Hodgkin's disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypergammaglobulinaemia benign monoclonal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inflammatory pseudotumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intestinal adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Invasive ductal breast carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Large intestine benign neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Laryngeal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Laryngeal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Laryngeal squamous cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leiomyoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leiomyosarcoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lentigo maligna
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leukaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lip and/or oral cavity cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Lip neoplasm malignant stage unspecified
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lipoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Lung adenocarcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
Lung cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
14 / 6988 (0.20%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 14 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 8 |
0 / 9 |
0 / 3 |
|
Lung carcinoma cell type unspecified recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung carcinoma cell type unspecified stage I
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung carcinoma cell type unspecified stage IV
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Lung neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung neoplasm malignant
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
17 / 6988 (0.24%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 17 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 9 |
0 / 5 |
|
Lymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
Lymphoma cutis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lymphoplasmacytoid lymphoma/immunocytoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Malignant anorectal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malignant ascites
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Malignant fibrous histiocytoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malignant melanoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
Malignant neoplasm of ampulla of Vater
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Malignant neoplasm of unknown primary site
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
Malignant peritoneal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malignant pleural effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mediastinum neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Melanocytic naevus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meningioma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meningioma benign
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastases to bone
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastases to central nervous system
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastases to liver
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastases to lung
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastases to lymph nodes
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Metastases to pancreas
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Metastases to peritoneum
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastatic bronchial carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
|
Metastatic carcinoma of the bladder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Metastatic gastric cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 1 |
|
Metastatic malignant melanoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
Metastatic neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Metastatic pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastatic salivary gland cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metastatic squamous cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Monoclonal gammopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myelofibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myeloproliferative disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nasal neoplasm benign
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Neoplasm malignant
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Neoplasm prostate
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neoplasm skin
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neuroendocrine carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Neuroendocrine carcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neuroendocrine tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Non-Hodgkin's lymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Non-Hodgkin's lymphoma recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Non-Hodgkin's lymphoma stage I
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Non-Hodgkin's lymphoma stage II
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Non-Hodgkin's lymphoma unspecified histology aggressive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Non-small cell lung cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Non-small cell lung cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Oesophageal adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal adenocarcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Oesophageal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Oesophageal carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
|
Oncocytoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oral cavity cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oropharyngeal cancer recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ovarian cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Ovarian cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
Ovarian cancer stage III
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ovarian germ cell teratoma benign
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancoast's tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Pancreatic carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
|
Pancreatic carcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 4 |
|
Pancreatic neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Paranasal sinus neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Parathyroid tumour benign
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pelvic neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Penile squamous cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Penis carcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peritoneal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pharyngeal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pharyngeal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pituitary tumour benign
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Plasma cell myeloma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pleomorphic adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pleural mesothelioma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Pleural mesothelioma malignant
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Polycythaemia vera
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostate cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
37 / 6996 (0.53%) |
38 / 6988 (0.54%) |
29 / 6958 (0.42%) |
|
occurrences causally related to treatment / all
|
0 / 37 |
0 / 38 |
0 / 29 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Prostate cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
|
Prostate cancer recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostate cancer stage II
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostatic adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal adenocarcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Rectal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Rectosigmoid cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Renal cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal cell carcinoma recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal oncocytoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Salivary gland adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Salivary gland cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Salivary gland cancer recurrent
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Salivary gland neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sarcoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sarcomatoid mesothelioma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skin cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Small cell lung cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Small cell lung cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
Small intestine carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal cord neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Splenic marginal zone lymphoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Squamous cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
Squamous cell carcinoma of lung
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Squamous cell carcinoma of pharynx
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Squamous cell carcinoma of skin
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thyroid adenoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thyroid cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thyroid cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Thyroid neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tongue cancer metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tongue neoplasm malignant stage unspecified
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tonsil cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tonsillar neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Transitional cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
1 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Transitional cell carcinoma metastatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Tumour associated fever
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tumour haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tumour pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Undifferentiated nasopharyngeal carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ureteric cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urethral cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary tract neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterine leiomyoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular disorders
|
|
|
|
|
Accelerated hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Angiodysplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Aortic aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
19 / 6988 (0.27%) |
19 / 6958 (0.27%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 20 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Aortic aneurysm rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
Aortic dissection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Aortic dissection rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Aortic rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Aortic stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Aortic thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Aorto-duodenal fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arterial rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arteriosclerosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Arteriovenous fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Circulatory collapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Deep vein thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
10 / 6988 (0.14%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic vascular disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Essential hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Extremity necrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femoral artery aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femoral artery embolism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femoral artery occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hot flush
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
8 / 6988 (0.11%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
1 / 18 |
0 / 8 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypertensive crisis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
10 / 6988 (0.14%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 11 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypertensive emergency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypotension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
10 / 6988 (0.14%) |
9 / 6958 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 10 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypothenar hammer syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypovolaemic shock
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Iliac artery occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intermittent claudication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leriche syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lymphoedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malignant hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Orthostatic hypotension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Penetrating atherosclerotic ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral arterial occlusive disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
17 / 6988 (0.24%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 17 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral artery aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
17 / 6996 (0.24%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral artery thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral circulatory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Peripheral embolism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral vascular disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Poor peripheral circulation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Shock
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Shock haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Steal syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subclavian artery occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subclavian artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Superior vena cava syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Temporal arteritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thrombophlebitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Varicose vein
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vasculitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Vena cava thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Venous insufficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Venous thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
General disorders and administration site conditions
|
|
|
|
|
Asthenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac death
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
Catheter site haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
2 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chest discomfort
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chest pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Death
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
42 / 6996 (0.60%) |
42 / 6988 (0.60%) |
34 / 6958 (0.49%) |
|
occurrences causally related to treatment / all
|
0 / 42 |
2 / 42 |
3 / 34 |
|
deaths causally related to treatment / all
|
0 / 42 |
2 / 42 |
3 / 34 |
|
Device battery issue
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device breakage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device defective
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device dislocation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device lead damage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device lead issue
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device malfunction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Device material issue
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Drowning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Drug withdrawal syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Euthanasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Fatigue
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gait disturbance
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
General physical health deterioration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Hernia obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypothermia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Impaired healing
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Implant site pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Injection site bruising
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malaise
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Medical device complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Multi-organ failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Non-cardiac chest pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
109 / 6996 (1.56%) |
115 / 6988 (1.65%) |
113 / 6958 (1.62%) |
|
occurrences causally related to treatment / all
|
0 / 118 |
3 / 122 |
1 / 124 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oedema peripheral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pyrexia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Stent-graft endoleak
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sudden cardiac death
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
33 / 6996 (0.47%) |
27 / 6988 (0.39%) |
27 / 6958 (0.39%) |
|
occurrences causally related to treatment / all
|
0 / 33 |
0 / 27 |
0 / 27 |
|
deaths causally related to treatment / all
|
0 / 33 |
0 / 27 |
0 / 27 |
|
Sudden death
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
6 / 6988 (0.09%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
0 / 6 |
0 / 11 |
|
deaths causally related to treatment / all
|
1 / 9 |
0 / 6 |
0 / 11 |
|
Systemic inflammatory response syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vessel puncture site haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Immune system disorders
|
|
|
|
|
Allergy to arthropod sting
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaphylactic reaction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaphylactic shock
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anti-neutrophil cytoplasmic antibody positive vasculitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Contrast media allergy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Drug hypersensitivity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypersensitivity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Reaction to food additive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sarcoidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Reproductive system and breast disorders
|
|
|
|
|
Acquired hydrocele
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acquired phimosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Benign prostatic hyperplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
26 / 6996 (0.37%) |
20 / 6988 (0.29%) |
25 / 6958 (0.36%) |
|
occurrences causally related to treatment / all
|
0 / 26 |
0 / 20 |
2 / 26 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Breast fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Calculus prostatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical dysplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cystocele
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endometrial hyperplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gynaecomastia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Menorrhagia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metrorrhagia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ovarian cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ovarian necrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postmenopausal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostatic mass
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostatism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Prostatomegaly
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterine cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterine haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterine polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterine prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uterovaginal prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vaginal prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Varicocele
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory, thoracic and mediastinal disorders
|
|
|
|
|
Acute pulmonary oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Acute respiratory distress syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Acute respiratory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 7 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
|
Aspiration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
Asthma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
9 / 6988 (0.13%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 12 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Atelectasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchial haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchial hyperreactivity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchial obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchiectasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchitis chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchospasm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Choking
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chronic obstructive pulmonary disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
45 / 6996 (0.64%) |
54 / 6988 (0.77%) |
39 / 6958 (0.56%) |
|
occurrences causally related to treatment / all
|
0 / 65 |
1 / 74 |
1 / 62 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 2 |
|
Chronic respiratory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cough
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diaphragmatic paralysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diffuse panbronchiolitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dyspnoea
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
29 / 6988 (0.41%) |
23 / 6958 (0.33%) |
|
occurrences causally related to treatment / all
|
1 / 12 |
11 / 30 |
8 / 24 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
|
Dyspnoea exertional
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Emphysema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epiglottic cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epiglottic oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epistaxis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
20 / 6988 (0.29%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
16 / 21 |
12 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemoptysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
5 / 6 |
2 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemothorax
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hydrothorax
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypoxia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Idiopathic pulmonary fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Interstitial lung disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Laryngeal oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung consolidation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nasal polyps
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nasal septum deviation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nocturnal dyspnoea
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Obstructive airways disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Organising pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pharyngeal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pharyngeal oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pleural adhesion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pleural effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
16 / 6996 (0.23%) |
2 / 6988 (0.03%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 3 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Pleurisy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pleuritic pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia aspiration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Pneumothorax
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumothorax spontaneous
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary arterial hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary congestion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary embolism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
17 / 6996 (0.24%) |
21 / 6988 (0.30%) |
17 / 6958 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 23 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 1 |
|
Pulmonary fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Pulmonary haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary mass
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 2 |
|
Respiratory arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory distress
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
1 / 3 |
0 / 2 |
0 / 3 |
|
Respiratory tract haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory tract inflammation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sleep apnoea syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thoracic haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tonsillar hypertrophy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vocal cord leukoplakia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psychiatric disorders
|
|
|
|
|
Affective disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Alcohol abuse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Alcoholism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anxiety
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bipolar I disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Completed suicide
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 0 |
|
Confusional state
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Conversion disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Delirium
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Depressed mood
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Depression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 13 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Insomnia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Major depression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mental status changes
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Panic attack
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Panic disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post-traumatic stress disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psychiatric decompensation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psychiatric symptom
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psychotic behaviour
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Somatoform disorder cardiovascular
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Suicidal ideation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Suicide attempt
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Investigations
|
|
|
|
|
Blood electrolytes decreased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Blood glucose decreased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Blood pressure increased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Blood urine present
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac stress test abnormal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clostridium test positive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ejection fraction decreased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Electrocardiogram abnormal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Glycosylated haemoglobin increased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematocrit decreased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Liver function test abnormal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lymph node palpable
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Occult blood positive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Scan myocardial perfusion abnormal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Weight increased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Injury, poisoning and procedural complications
|
|
|
|
|
Abdominal wound dehiscence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Accidental overdose
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acetabulum fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Alcohol poisoning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia postoperative
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaesthetic complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anastomotic complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anastomotic stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anastomotic ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ankle fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arterial injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arterial restenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arthropod sting
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Back injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bone contusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bone fissure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Brain contusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Brain herniation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Burns second degree
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Burns third degree
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Carbon monoxide poisoning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid artery restenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical vertebral fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Chemical peritonitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chest injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clavicle fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Concussion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Contusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Craniocerebral injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
Cystitis radiation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Extradural haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
Face injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Facial bones fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fall
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femoral neck fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femur fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 11 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fibula fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Foot fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Forearm fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Foreign body
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fractured ischium
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gas poisoning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal stoma complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gun shot wound
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematuria traumatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hand fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Head injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Heat exhaustion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Heat stroke
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hip fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
5 / 6988 (0.07%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Humerus fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Incisional hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Incisional hernia, obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inflammation of wound
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intestinal anastomosis complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Joint capsule rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Joint dislocation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Joint injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Laceration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ligament injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ligament rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ligament sprain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Limb crushing injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Limb injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Limb traumatic amputation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lip injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lower limb fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lumbar vertebral fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meniscus injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Multiple fractures
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Multiple injuries
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle strain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neck injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Osteoradionecrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Overdose
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Pancreatic leak
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Patella fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pelvic fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral arterial reocclusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral artery restenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Periprosthetic fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumothorax traumatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Poisoning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post gastric surgery syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
3 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural haematuria
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
3 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
4 / 12 |
2 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural persistent drain fluid
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post-traumatic pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postoperative ileus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postoperative respiratory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postoperative thoracic procedure complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postoperative wound complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postpericardiotomy syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Procedural haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
2 / 7 |
2 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Procedural hypotension
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Procedural pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pubis fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary contusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Radial nerve injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Radiation dysphagia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Radius fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Remnant gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rib fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
8 / 6988 (0.11%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Road traffic accident
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
Scapula fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Seroma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skull fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Soft tissue injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal compression fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal cord injury cervical
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Splenic rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sternal fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subdural haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
3 / 5 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subdural haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Suture related complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tendon injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tendon rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thermal burn
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thoracic vertebral fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tibia fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
6 / 6988 (0.09%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Toxicity to various agents
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Traumatic haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
13 / 6988 (0.19%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
5 / 14 |
2 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Traumatic haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Traumatic haemothorax
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Traumatic intracranial haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
18 / 6988 (0.26%) |
17 / 6958 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
2 / 20 |
4 / 19 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
|
Traumatic spinal cord compression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ulna fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Upper limb fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary retention postoperative
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary tract injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
VIIIth nerve injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular graft complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular graft occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular graft thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular procedure complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular pseudoaneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Venous injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound dehiscence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wrist fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Congenital, familial and genetic disorders
|
|
|
|
|
Atrial septal defect
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac disorders
|
|
|
|
|
Acute coronary syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Acute left ventricular failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
Acute myocardial infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
19 / 6988 (0.27%) |
20 / 6958 (0.29%) |
|
occurrences causally related to treatment / all
|
0 / 28 |
1 / 19 |
1 / 20 |
|
deaths causally related to treatment / all
|
0 / 26 |
1 / 17 |
1 / 17 |
|
Adams-Stokes syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Angina pectoris
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
51 / 6996 (0.73%) |
51 / 6988 (0.73%) |
45 / 6958 (0.65%) |
|
occurrences causally related to treatment / all
|
1 / 53 |
0 / 55 |
0 / 47 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Angina unstable
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Aortic valve disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Aortic valve stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
|
Arrhythmia supraventricular
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arteriosclerosis coronary artery
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Atrial fibrillation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
67 / 6996 (0.96%) |
74 / 6988 (1.06%) |
94 / 6958 (1.35%) |
|
occurrences causally related to treatment / all
|
0 / 73 |
0 / 88 |
0 / 104 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atrial flutter
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
16 / 6996 (0.23%) |
13 / 6988 (0.19%) |
14 / 6958 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
0 / 13 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atrial tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atrial thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atrioventricular block
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Atrioventricular block complete
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
3 / 6988 (0.04%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
2 / 14 |
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atrioventricular block second degree
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
2 / 4 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bifascicular block
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bradyarrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bradycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bundle branch block left
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bundle branch block right
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
7 / 6988 (0.10%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
1 / 6 |
0 / 8 |
0 / 8 |
|
deaths causally related to treatment / all
|
1 / 4 |
0 / 5 |
0 / 5 |
|
Cardiac asthma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
58 / 6996 (0.83%) |
54 / 6988 (0.77%) |
53 / 6958 (0.76%) |
|
occurrences causally related to treatment / all
|
0 / 73 |
1 / 69 |
0 / 70 |
|
deaths causally related to treatment / all
|
0 / 13 |
0 / 4 |
0 / 7 |
|
Cardiac failure acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
4 / 6988 (0.06%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 6 |
0 / 1 |
0 / 3 |
|
Cardiac failure chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
19 / 6988 (0.27%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 25 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 1 |
|
Cardiac failure congestive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
51 / 6996 (0.73%) |
70 / 6988 (1.00%) |
53 / 6958 (0.76%) |
|
occurrences causally related to treatment / all
|
0 / 60 |
0 / 97 |
0 / 79 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 14 |
0 / 5 |
|
Cardiac hypertrophy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac tamponade
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac valve disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardiac ventricular thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cardio-respiratory arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
6 / 6988 (0.09%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 6 |
|
Cardiogenic shock
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
4 / 6988 (0.06%) |
9 / 6958 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 8 |
|
Cardiomyopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Cardiopulmonary failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Cardiovascular insufficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
|
Conduction disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cor pulmonale chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Coronary artery disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
6 / 6988 (0.09%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Coronary artery occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Coronary artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Coronary artery thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Dressler's syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrocardiac syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Heart valve incompetence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intracardiac thrombus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ischaemic cardiomyopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Left ventricular dysfunction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Left ventricular failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
Low cardiac output syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mitral valve calcification
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mitral valve incompetence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mitral valve prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myocardial fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myocardial infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
10 / 6988 (0.14%) |
9 / 6958 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 10 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 11 |
0 / 10 |
0 / 9 |
|
Myocardial ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Myocardial oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myocardial rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Myocarditis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nodal arrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nodal rhythm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Palpitations
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pericardial effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pericardial haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pericarditis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulseless electrical activity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Right ventricular failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sick sinus syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
8 / 6988 (0.11%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 8 |
0 / 9 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinoatrial block
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinus arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinus arrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinus bradycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
12 / 6988 (0.17%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
4 / 12 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinus tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subendocardial ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Supraventricular extrasystoles
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Supraventricular tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
1 / 4 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Systolic dysfunction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tachyarrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tachycardia paroxysmal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ventricular arrhythmia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Ventricular dysfunction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ventricular extrasystoles
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ventricular fibrillation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
4 / 6988 (0.06%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 5 |
|
Ventricular tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
17 / 6988 (0.24%) |
17 / 6958 (0.24%) |
|
occurrences causally related to treatment / all
|
1 / 12 |
0 / 20 |
1 / 20 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
Nervous system disorders
|
|
|
|
|
Amyotrophic lateral sclerosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Brain injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Brain oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Brain stem infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Brain stem syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid arteriosclerosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid artery aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid artery disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
15 / 6988 (0.21%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 17 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carotid sinus syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Carpal tunnel syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cauda equina syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Central nervous system lesion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebellar ataxia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebral arteriosclerosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Cerebral cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebral haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
0 / 2 |
2 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
|
Cerebral infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
Cerebral ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebral microangiopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebrospinal fluid leakage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebrovascular accident
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
Cerebrovascular disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical cord compression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical myelopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical radiculopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervicobrachial syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cluster headache
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cognitive disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Complex regional pain syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Convulsion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Dementia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Dementia Alzheimer's type
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Demyelinating polyneuropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic neuropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dizziness
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
9 / 6988 (0.13%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 10 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epilepsy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Extrapyramidal disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Grand mal convulsion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Guillain-Barre syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhage intracranial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
Haemorrhagic stroke
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
6 / 10 |
1 / 5 |
2 / 3 |
|
deaths causally related to treatment / all
|
3 / 6 |
0 / 3 |
1 / 1 |
|
Haemorrhagic transformation stroke
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Headache
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypercapnic coma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypertensive encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypoxic-ischaemic encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
IIIrd nerve paralysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intracranial aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intraventricular haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ischaemic cerebral infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Ischaemic stroke
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
11 / 6988 (0.16%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 19 |
1 / 11 |
1 / 11 |
|
deaths causally related to treatment / all
|
0 / 12 |
0 / 8 |
1 / 9 |
|
Leukoencephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Loss of consciousness
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lumbar radiculopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metabolic encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Migraine
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mononeuritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Monoparesis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Multiple sclerosis relapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Muscle contractions involuntary
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myelopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myoclonus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nerve root compression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neuralgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neuritis cranial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neuropathy peripheral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Normal pressure hydrocephalus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Occipital neuralgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Orthostatic intolerance
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Paraesthesia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Parkinson's disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Parkinsonism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peripheral nerve paresis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Polyneuropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Presyncope
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
3 / 6988 (0.04%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
1 / 3 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psychomotor hyperactivity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Quadriparesis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Radiculopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ruptured cerebral aneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Sciatica
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Senile dementia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Serotonin syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Somnolence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal claudication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal cord compression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Status epilepticus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Subarachnoid haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
Syncope
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
37 / 6988 (0.53%) |
31 / 6958 (0.45%) |
|
occurrences causally related to treatment / all
|
0 / 30 |
3 / 39 |
1 / 33 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Temporal lobe epilepsy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tension headache
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Toxic encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Transient global amnesia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Transient ischaemic attack
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Trigeminal neuralgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Uraemic encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
VIIth nerve paralysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
VIth nerve paresis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vagus nerve disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular encephalopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vascular parkinsonism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vertebral artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vertebrobasilar insufficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Blood and lymphatic system disorders
|
|
|
|
|
Anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
12 / 6988 (0.17%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
5 / 12 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia macrocytic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia megaloblastic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia of chronic disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia of malignant disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 7 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anaemia vitamin B12 deficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Aplastic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Coagulation factor deficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Coagulopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Febrile neutropenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemolysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhagic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
2 / 4 |
2 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Heparin-induced thrombocytopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypercoagulation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypochromic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Immune thrombocytopenic purpura
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Increased tendency to bruise
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Iron deficiency anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
24 / 6988 (0.34%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
2 / 3 |
10 / 25 |
3 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leukocytosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leukopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lymphadenopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Microcytic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
4 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nephrogenic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neutropenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Normochromic normocytic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancytopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pernicious anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Splenic haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Splenomegaly
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spontaneous haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
1 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spontaneous haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thrombocytopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
8 / 6988 (0.11%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
5 / 8 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ear and labyrinth disorders
|
|
|
|
|
Acute vestibular syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Auricular perichondritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Deafness
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Deafness unilateral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inner ear disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meniere's disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Middle ear effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Presbyacusis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sudden hearing loss
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tympanic membrane perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vertigo
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
1 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vertigo labyrinthine
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vertigo positional
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Eye disorders
|
|
|
|
|
Age-related macular degeneration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Angle closure glaucoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Blindness unilateral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cataract
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
10 / 6988 (0.14%) |
16 / 6958 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 11 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cataract nuclear
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Conjunctival haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
2 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic retinopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diplopia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endocrine ophthalmopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Extraocular muscle paresis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Eye haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Eyelid ptosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Glaucoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Macular degeneration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Macular fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Open angle glaucoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Opsoclonus myoclonus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Optic ischaemic neuropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pterygium
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal artery embolism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal artery occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal degeneration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal detachment
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retinal vein occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Strabismus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tolosa-Hunt syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vitreous haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
2 / 2 |
1 / 1 |
2 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal disorders
|
|
|
|
|
Abdominal adhesions
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal discomfort
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal hernia obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal pain lower
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal pain upper
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal wall haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acute abdomen
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
Anal fissure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Appendiceal mucocoele
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ascites
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Barrett's oesophagus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colitis ischaemic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colitis ulcerative
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Constipation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
9 / 6988 (0.13%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 9 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Crohn's disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dental caries
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diaphragmatic hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diarrhoea
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
7 / 6988 (0.10%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dieulafoy's vascular malformation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diverticular perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Diverticulitis intestinal haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
3 / 5 |
1 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diverticulum
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
8 / 6988 (0.11%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
2 / 9 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diverticulum intestinal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diverticulum intestinal haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
11 / 6988 (0.16%) |
12 / 6958 (0.17%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
8 / 12 |
12 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Duodenal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Duodenal ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
3 / 5 |
2 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Duodenal ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
3 / 4 |
5 / 7 |
5 / 7 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
|
Duodenitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dyspepsia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dysphagia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enteritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enterocolitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enterocolitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
2 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enterovesical fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Erosive duodenitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Erosive oesophagitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Faecalith
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Femoral hernia, obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Food poisoning
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric polyps
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
13 / 6988 (0.19%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
2 / 4 |
6 / 14 |
4 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
18 / 6988 (0.26%) |
14 / 6958 (0.20%) |
|
occurrences causally related to treatment / all
|
4 / 7 |
13 / 18 |
9 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastric ulcer perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
Gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
17 / 6988 (0.24%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
1 / 11 |
3 / 18 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastritis atrophic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastritis erosive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastritis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
2 / 3 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastritis hypertrophic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroduodenitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroduodenitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal angiodysplasia haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal erosion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
26 / 6988 (0.37%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
7 / 9 |
13 / 27 |
12 / 15 |
|
deaths causally related to treatment / all
|
1 / 2 |
0 / 4 |
1 / 1 |
|
Gastrointestinal mucosal disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal necrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Gastrointestinal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal polyp haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
1 / 2 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
5 / 6988 (0.07%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 5 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal vascular malformation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrooesophageal reflux disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 11 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gingival bleeding
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematemesis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematochezia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhagic erosive gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
3 / 3 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhoidal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
2 / 3 |
2 / 4 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhoids
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
2 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hiatus hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ileus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Ileus paralytic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Impaired gastric emptying
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 12 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inguinal hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
21 / 6996 (0.30%) |
25 / 6988 (0.36%) |
26 / 6958 (0.37%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 25 |
0 / 27 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inguinal hernia strangulated
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inguinal hernia, obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intestinal infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Intestinal ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
Intestinal obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Intestinal perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Intussusception
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Irritable bowel syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Large intestinal ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Large intestine perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Large intestine polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
12 / 6988 (0.17%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 12 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lower gastrointestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
2 / 3 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mallory-Weiss syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 4 |
2 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mechanical ileus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Melaena
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
3 / 4 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mouth haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nausea
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal achalasia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophageal varices haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophagitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Oesophagitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatic duct obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatic fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatic mass
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Pancreatitis acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
8 / 6988 (0.11%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
1 / 8 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatitis chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Papilla of Vater stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Parotid gland inflammation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peptic ulcer haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
2 / 4 |
2 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peritoneal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Proctitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Proctitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
2 / 5 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Reflux gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Small intestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Small intestinal obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Small intestinal perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Thrombosis mesenteric vessel
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tongue blistering
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tooth disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Toothache
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Umbilical hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Umbilical hernia, obstructive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Upper gastrointestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 7 |
5 / 7 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
|
Volvulus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Volvulus of small bowel
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Vomiting
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatobiliary disorders
|
|
|
|
|
Acute hepatic failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bile duct stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bile duct stone
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
1 / 6988 (0.01%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 10 |
0 / 1 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biliary colic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biliary dyskinesia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biliary fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biloma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholangitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Cholangitis sclerosing
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholecystitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
10 / 6988 (0.14%) |
17 / 6958 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 10 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholecystitis acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
7 / 6988 (0.10%) |
11 / 6958 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Cholecystitis chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholelithiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
31 / 6996 (0.44%) |
15 / 6988 (0.21%) |
18 / 6958 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 31 |
0 / 15 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholestasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Chronic hepatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cirrhosis alcoholic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Drug-induced liver injury
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gallbladder disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatic cirrhosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatic failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Hepatic vein thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Hepatomegaly
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatorenal failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hydrocholecystis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperplastic cholecystopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Jaundice
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Jaundice cholestatic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Liver disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Non-alcoholic steatohepatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Portal vein thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skin and subcutaneous tissue disorders
|
|
|
|
|
Actinic keratosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Angioedema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
2 / 3 |
0 / 2 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cutaneous sarcoidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Decubitus ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dermal cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dermatitis allergic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic foot
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Drug eruption
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dry gangrene
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ecchymosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Eczema
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperhidrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperkeratosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypersensitivity vasculitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Panniculitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psoriasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pyoderma gangrenosum
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rash
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rash generalised
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skin haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skin ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Stevens-Johnson syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urticaria
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal and urinary disorders
|
|
|
|
|
Acute prerenal failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder diverticulum
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder neck sclerosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bladder tamponade
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Calculus bladder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Calculus ureteric
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Calculus urethral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Calculus urinary
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cystitis haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cystitis noninfective
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic nephropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Glomerulonephritis membranoproliferative
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Glomerulonephritis membranous
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematuria
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
9 / 6988 (0.13%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
2 / 3 |
3 / 9 |
9 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemorrhage urinary tract
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hydronephrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypertensive nephropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nephrolithiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
21 / 6988 (0.30%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
2 / 22 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neurogenic bladder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Obstructive uropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pelvi-ureteric obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal artery stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal colic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal cyst ruptured
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal failure
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
6 / 6988 (0.09%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 6 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 2 |
|
Renal failure acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
32 / 6988 (0.46%) |
32 / 6958 (0.46%) |
|
occurrences causally related to treatment / all
|
0 / 34 |
0 / 34 |
1 / 32 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
Renal failure chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
Renal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal impairment
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Renal tubular acidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Stress urinary incontinence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tubulointerstitial nephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Ureteric rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Ureteric stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urethral stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary bladder haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary bladder polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary incontinence
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary retention
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary tract disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endocrine disorders
|
|
|
|
|
Autoimmune thyroiditis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Goitre
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperthyroidism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypothyroidism
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Inappropriate antidiuretic hormone secretion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Toxic nodular goitre
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Musculoskeletal and connective tissue disorders
|
|
|
|
|
Ankylosing spondylitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arthralgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
10 / 6988 (0.14%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 10 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arthropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Back pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bone pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bursitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cervical spinal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chondrocalcinosis pyrophosphate
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chondropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Costochondritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dupuytren's contracture
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Facet joint syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fibromyalgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Foot deformity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fracture malunion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Fracture nonunion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gouty arthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Groin pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haemarthrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hand deformity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intervertebral disc compression
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intervertebral disc degeneration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intervertebral disc disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intervertebral disc protrusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
8 / 6988 (0.11%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 11 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Jaw cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Jaw disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Joint ankylosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Joint effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lumbar spinal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meniscal degeneration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Mobility decreased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Monarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle hypertrophy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle spasms
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscular weakness
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Musculoskeletal chest pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
20 / 6996 (0.29%) |
16 / 6988 (0.23%) |
22 / 6958 (0.32%) |
|
occurrences causally related to treatment / all
|
1 / 20 |
0 / 17 |
0 / 23 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Musculoskeletal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myalgia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myalgia intercostal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myopathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myositis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neck pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Osteoarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
59 / 6996 (0.84%) |
54 / 6988 (0.77%) |
54 / 6958 (0.78%) |
|
occurrences causally related to treatment / all
|
0 / 62 |
0 / 57 |
0 / 59 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Osteonecrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Osteoporosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pain in extremity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pain in jaw
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Periarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Polyarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Polymyalgia rheumatica
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Polymyositis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Psoriatic arthropathy
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Resorption bone increased
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rhabdomyolysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rheumatoid arthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rotator cuff syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
12 / 6988 (0.17%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 12 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sacroiliitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal column stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
9 / 6958 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal osteoarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spinal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spondylolisthesis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Spondylolysis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sympathetic posterior cervical syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Synovial cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Systemic lupus erythematosus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tendon calcification
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tendon disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tendonitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Trigger finger
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infections and infestations
|
|
|
|
|
Abdominal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Abdominal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Abdominal wall abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abdominal wall infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abscess limb
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Abscess neck
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acquired immunodeficiency syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Acute sinusitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Amoebiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Anal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Appendicitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
7 / 6988 (0.10%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Appendicitis perforated
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Arthritis infective
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Atypical pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Avian influenza
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bacteraemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bacterial infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bacterial prostatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bacterial pyelonephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bartholin's abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Biliary sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Breast abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
19 / 6996 (0.27%) |
22 / 6988 (0.31%) |
10 / 6958 (0.14%) |
|
occurrences causally related to treatment / all
|
1 / 20 |
1 / 27 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchitis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bronchopneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
12 / 6988 (0.17%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 12 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
Bronchopulmonary aspergillosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Bursitis infective
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Campylobacter gastroenteritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cellulitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
12 / 6988 (0.17%) |
17 / 6958 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 13 |
1 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cellulitis laryngeal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cellulitis of male external genital organ
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cerebral toxoplasmosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Chest wall abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholangitis suppurative
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cholecystitis infective
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Chronic sinusitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clostridium colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clostridium difficile colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Clostridium difficile infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Clostridium difficile sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Colonic abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Congo-Crimean haemorrhagic fever
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Cystitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dengue fever
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device related infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Device related sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic foot infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic gangrene
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diverticulitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
1 / 12 |
0 / 12 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
Ear infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Emphysematous cholecystitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Encephalitis brain stem
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endocarditis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Endocarditis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enteritis infectious
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enterococcal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Enterocolitis infectious
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epididymitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Epiglottitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Erysipelas
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Escherichia bacteraemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Escherichia pyelonephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Escherichia sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Escherichia urinary tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Extradural abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Eye infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Furuncle
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gangrene
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
Gastritis viral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
18 / 6988 (0.26%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 18 |
1 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis norovirus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis rotavirus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis salmonella
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastroenteritis viral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gastrointestinal infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Gingivitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Groin abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Groin infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
H1N1 influenza
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Haematoma infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Helicobacter gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Helicobacter infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatitis A
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hepatitis viral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Herpes simplex meningoencephalitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Herpes zoster
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Incision site infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infected dermal cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infected fistula
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Infected skin ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Infectious colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infectious pleural effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Infective exacerbation of chronic obstructive airways disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Influenza
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Intervertebral discitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Klebsiella sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Labyrinthitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Laryngitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Leishmaniasis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Listeria sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Liver abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lobar pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Localised infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Lower respiratory tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
|
Lower respiratory tract infection bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lung infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Lyme disease
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malaria
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meningitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Meningitis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Muscle abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Myringitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nasal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Nasopharyngitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Necrotising fasciitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Neutropenic sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
Ophthalmic herpes zoster
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Orchitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Osteomyelitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Otitis externa
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Otitis media acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Otitis media chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pancreatic abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Paraspinal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Parotitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pelvic abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Periodontitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Perirectal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Peritonitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
|
Peritonsillar abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pharyngeal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pilonidal cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumococcal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
|
Pneumocystis jirovecii pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
76 / 6996 (1.09%) |
77 / 6988 (1.10%) |
69 / 6958 (0.99%) |
|
occurrences causally related to treatment / all
|
1 / 83 |
0 / 86 |
1 / 72 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 7 |
1 / 10 |
|
Pneumonia bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
6 / 6988 (0.09%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 6 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
|
Pneumonia cytomegaloviral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia haemophilus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia influenzal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia legionella
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia necrotising
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia pneumococcal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia pseudomonal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia streptococcal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pneumonia viral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Post procedural pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Postoperative wound infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
8 / 6958 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Proctitis infectious
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pseudomembranous colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pseudomonal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pseudomonas infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pulmonary sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Pulmonary tuberculosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pyelonephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pyelonephritis acute
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Pyopneumothorax
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rectal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Respiratory tract infection viral
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Retroperitoneal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Rhinitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Salmonellosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Scrotal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
17 / 6988 (0.24%) |
20 / 6958 (0.29%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 18 |
0 / 20 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 8 |
0 / 5 |
|
Septic necrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Septic shock
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
12 / 6988 (0.17%) |
7 / 6958 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 12 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 5 |
0 / 8 |
0 / 3 |
|
Sialoadenitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Sinusitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Skin infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Soft tissue infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Staphylococcal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Streptococcal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Streptococcal infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subacute endocarditis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Subcutaneous abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tonsillitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Toxoplasmosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tracheitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tracheobronchitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Tuberculosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Upper respiratory tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urethritis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary bladder abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
28 / 6988 (0.40%) |
27 / 6958 (0.39%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 30 |
0 / 30 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urinary tract infection pseudomonal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Urosepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
19 / 6988 (0.27%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 19 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
Vestibular neuronitis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Viral diarrhoea
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Viral infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound infection bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Wound infection staphylococcal
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Yersinia infection
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metabolism and nutrition disorders
|
|
|
|
|
Abnormal loss of weight
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Decreased appetite
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Dehydration
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
11 / 6988 (0.16%) |
9 / 6958 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 13 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetes mellitus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
15 / 6988 (0.21%) |
15 / 6958 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 17 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetes mellitus inadequate control
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
11 / 6988 (0.16%) |
12 / 6958 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 14 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Diabetic complication
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Diabetic ketoacidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Electrolyte imbalance
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
Failure to thrive
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Gout
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypercalcaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperglycaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyperkalaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
Hypocalcaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypoglycaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
6 / 6958 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypokalaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypomagnesaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hyponatraemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Hypovolaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lactic acidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Lactose intolerance
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Malnutrition
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Metabolic acidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Obesity
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Type 1 diabetes mellitus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
|
Type 2 diabetes mellitus
|
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
6 / 6988 (0.09%) |
3 / 6958 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |